Table 2 MRI characteristics and distribution of pancreatic metastases
From: Imaging of pancreatic metastases from renal cell carcinoma
Patient | N° | Diameter (mm) | Location | T1 GRE unenh | N° T1 GRE unenh | T2 TSE FatSat | N° T2 TSE FatSat | DWI 800 | N° DWI 800 | Pattern art enhancement | N° Art | Portal enhancement | N° portal | Venous enhancement | N° venous |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2 | 2 | 16/22 | Head/Body | HypoInt | 2 | HyperInt | 2 | HyperInt | 2 | Homogeneous | 2 | HyperInt | 2 | IsoInt | 1 |
3 | 1 | 40 | Head | HypoInt | 1 | Hyper/IsoInt | 1 | HyperInt | 1 | Rim | 1 | Hyper/IsoInt | 1 | IsoInt | 1 |
10 | 1 | 13 | Head | HypoInt | 1 | HyperInt | 1 | HyperInt | 1 | Homogeneous | 1 | HyperInt | 1 | Hyper/IsoInt | 1 |
12 | 1 | 39 | Tail | HypoInt | 1 | IsoInt | 1 | HyperInt | 1 | Rim | 1 | Hyper/IsoInt | 1 | IsoInt | 1 |
13 | 2 | 16/11 | Body/Tail | HypoInt | 2 | HyperInt | 2 | IsoInt | 1 | IsoInt | 2 | IsoInt | 2 | IsoInt | 1 |
Sum | 7 | 7 | 7 | 6 | 7 | 7 | 5 |